Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 51

1.

Global DNA Methylation and Histone Posttranslational Modifications in Human and Nonhuman Primate Brain in Association with Prenatal Alcohol Exposure.

Jarmasz JS, Stirton H, Basalah D, Davie JR, Clarren SK, Astley SJ, Del Bigio MR.

Alcohol Clin Exp Res. 2019 Jun;43(6):1145-1162. doi: 10.1111/acer.14052. Epub 2019 May 10.

2.

An investigation of intra-individual variability in children with fetal alcohol spectrum disorder (FASD).

Ali S, Kerns KA, Mulligan BP, Olson HC, Astley SJ.

Child Neuropsychol. 2018 Jul;24(5):617-637. doi: 10.1080/09297049.2017.1302579. Epub 2017 Mar 16.

3.
4.

Invited commentary on Australian fetal alcohol spectrum disorder diagnostic guidelines.

Astley SJ.

BMC Pediatr. 2014 Apr 1;14:85. doi: 10.1186/1471-2431-14-85.

5.

The value of a FASD diagnosis (2013).

Astley SJ.

J Popul Ther Clin Pharmacol. 2014;21(1):e81-e105. Epub 2014 Mar 6.

PMID:
24615395
6.

Validation of the fetal alcohol spectrum disorder (FASD) 4-Digit Diagnostic Code.

Astley SJ.

J Popul Ther Clin Pharmacol. 2013;20(3):e416-67. Epub 2013 Nov 15.

PMID:
24323701
7.

Sensory control of balance: a comparison of children with fetal alcohol spectrum disorders to children with typical development.

Jirikowic TL, McCoy SW, Lubetzky-Vilnai A, Price R, Ciol MA, Kartin D, Hsu LY, Gendler B, Astley SJ.

J Popul Ther Clin Pharmacol. 2013;20(3):e212-28. Epub 2013 Sep 6.

8.
10.

Magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Astley SJ, Aylward EH, Olson HC, Kerns K, Brooks A, Coggins TE, Davies J, Dorn S, Gendler B, Jirikowic T, Kraegel P, Maravilla K, Richards T.

Alcohol Clin Exp Res. 2009 Oct;33(10):1671-89. doi: 10.1111/j.1530-0277.2009.01004.x. Epub 2009 Jul 1.

11.

Magnetic resonance spectroscopy outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Astley SJ, Richards T, Aylward EH, Olson HC, Kerns K, Brooks A, Coggins TE, Davies J, Dorn S, Gendler B, Jirikowic T, Kraegel P, Maravilla K.

Magn Reson Imaging. 2009 Jul;27(6):760-78. doi: 10.1016/j.mri.2009.01.003. Epub 2009 Apr 2.

12.

Neuropyschological and behavioral outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Astley SJ, Olson HC, Kerns K, Brooks A, Aylward EH, Coggins TE, Davies J, Dorn S, Gendler B, Jirikowic T, Kraegel P, Maravilla K, Richards T.

Can J Clin Pharmacol. 2009 Winter;16(1):e178-201. Epub 2009 Mar 27.

13.

Functional magnetic resonance imaging outcomes from a comprehensive magnetic resonance study of children with fetal alcohol spectrum disorders.

Astley SJ, Aylward EH, Olson HC, Kerns K, Brooks A, Coggins TE, Davies J, Dorn S, Gendler B, Jirikowic T, Kraegel P, Maravilla K, Richards T.

J Neurodev Disord. 2009 Mar;1(1):61-80. doi: 10.1007/s11689-009-9004-0. Epub 2009 Mar 12.

14.

Exploring the utility of narrative analysis in diagnostic decision making: picture-bound reference, elaboration, and fetal alcohol spectrum disorders.

Thorne JC, Coggins TE, Carmichael Olson H, Astley SJ.

J Speech Lang Hear Res. 2007 Apr;50(2):459-74.

PMID:
17463241
15.

Comparison of the 4-digit diagnostic code and the Hoyme diagnostic guidelines for fetal alcohol spectrum disorders.

Astley SJ.

Pediatrics. 2006 Oct;118(4):1532-45. Erratum in: Pediatrics. 2007 Jan;119(1):227.

PMID:
17015544
16.

Characterization of anti-myosin monoclonal antibodies.

Nelson PN, Astley SJ, Roden D, Waldron E, Baig K, Caforio AL, Koutedakis Y, Perera S, Spry C.

Hybridoma (Larchmt). 2005 Dec;24(6):314-8.

PMID:
16332199
17.

Fetal alcohol syndrome prevention in Washington State: evidence of success.

Astley SJ.

Paediatr Perinat Epidemiol. 2004 Sep;18(5):344-51.

PMID:
15367321
18.

Demystified...recombinant antibodies.

Smith KA, Nelson PN, Warren P, Astley SJ, Murray PG, Greenman J.

J Clin Pathol. 2004 Sep;57(9):912-7. Review.

19.

Reactivity and isotype profiling of monoclonal antibodies using multiple antigenic peptides.

Waldron EE, Murray P, Kolar Z, Young L, Brown C, Reynolds G, Baumforth K, Toomey S, Astley SJ, Perera SA, Nelson PN.

Hybrid Hybridomics. 2002 Oct;21(5):393-8.

PMID:
12470483
20.

Application of the fetal alcohol syndrome facial photographic screening tool in a foster care population.

Astley SJ, Stachowiak J, Clarren SK, Clausen C.

J Pediatr. 2002 Nov;141(5):712-7.

PMID:
12410204
21.
22.
23.
24.
25.

Fit of bicycle safety helmets and risk of head injuries in children.

Rivara FP, Astley SJ, Clarren SK, Thompson DC, Thompson RS.

Inj Prev. 1999 Sep;5(3):194-7.

26.
27.

Outcomes of suction curettage and mifepristone abortion in the United States. A prospective comparison study.

Jensen JT, Astley SJ, Morgan E, Nichols MD.

Contraception. 1999 Mar;59(3):153-9.

PMID:
10382077
28.

Fetal alcohol syndrome: changes in craniofacial form with age, cognition, and timing of ethanol exposure in the macaque.

Astley SJ, Magnuson SI, Omnell LM, Clarren SK.

Teratology. 1999 Mar;59(3):163-72.

PMID:
10194807
29.

Selective dorsal rhizotomy: efficacy and safety in an investigator-masked randomized clinical trial.

McLaughlin JF, Bjornson KF, Astley SJ, Graubert C, Hays RM, Roberts TS, Price R, Temkin N.

Dev Med Child Neurol. 1998 Apr;40(4):220-32. Review.

30.

Quantitative comparison of conventional spin echo and fast spin echo during brain myelination.

Shaw DW, Weinberger E, Astley SJ, Tsuruda JS.

J Comput Assist Tomogr. 1997 Nov-Dec;21(6):867-71.

PMID:
9386274
31.
32.

Purkinje cell deficits in nonhuman primates following weekly exposure to ethanol during gestation.

Bonthius DJ, Bonthius NE, Napper RM, Astley SJ, Clarren SK, West JR.

Teratology. 1996 Apr;53(4):230-6.

PMID:
8864164
33.

A fetal alcohol syndrome screening tool.

Astley SJ, Clarren SK.

Alcohol Clin Exp Res. 1995 Dec;19(6):1565-71.

PMID:
8749828
34.

Magnetic resonance imaging and spectroscopy in fetal ethanol exposed Macaca nemestrina.

Astley SJ, Weinberger E, Shaw DW, Richards TL, Clarren SK.

Neurotoxicol Teratol. 1995 Sep-Oct;17(5):523-30.

PMID:
8551998
35.

Liver function in patients with cystic fibrosis ingesting fish oil.

Henderson WR Jr, Astley SJ, Ramsey BW.

J Pediatr. 1994 Sep;125(3):504-5. No abstract available.

PMID:
8071770
36.

The role of selective dorsal rhizotomy in cerebral palsy: critical evaluation of a prospective clinical series.

McLaughlin JF, Bjornson KF, Astley SJ, Hays RM, Hoffinger SA, Armantrout EA, Roberts TS.

Dev Med Child Neurol. 1994 Sep;36(9):755-69.

PMID:
7926327
37.

Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.

Henderson WR Jr, Astley SJ, McCready MM, Kushmerick P, Casey S, Becker JW, Ramsey BW.

J Pediatr. 1994 Mar;124(3):400-8.

PMID:
8120709
38.

Immune function in offspring of nonhuman primates (Macaca nemestrina) exposed weekly to 1.8 g/kg ethanol during pregnancy: preliminary observations.

Grossmann A, Astley SJ, Liggitt HD, Clarren SK, Shiota F, Kennedy B, Thouless ME, Maggio-Price L.

Alcohol Clin Exp Res. 1993 Aug;17(4):822-7.

PMID:
8214421
39.

Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.

Ramsey BW, Astley SJ, Aitken ML, Burke W, Colin AA, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Schidlow DV, et al.

Am Rev Respir Dis. 1993 Jul;148(1):145-51.

PMID:
8317790
40.

Efficacy of aerosolized tobramycin in patients with cystic fibrosis.

Ramsey BW, Dorkin HL, Eisenberg JD, Gibson RL, Harwood IR, Kravitz RM, Schidlow DV, Wilmott RW, Astley SJ, McBurnie MA, et al.

N Engl J Med. 1993 Jun 17;328(24):1740-6.

41.

Cognitive and behavioral deficits in nonhuman primates associated with very early embryonic binge exposures to ethanol.

Clarren SK, Astley SJ, Gunderson VM, Spellman D.

J Pediatr. 1992 Nov;121(5 Pt 1):789-96.

PMID:
1432435
42.

Electrodiagnosis reliability in the diagnosis of infant botulism.

Graf WD, Hays RM, Astley SJ, Mendelman PM.

J Pediatr. 1992 May;120(5):747-9.

PMID:
1315854
43.

Dialysis-associated seizures in children and adolescents.

Glenn CM, Astley SJ, Watkins SL.

Pediatr Nephrol. 1992 Mar;6(2):182-6.

PMID:
1571218
45.

Analysis of facial shape in children gestationally exposed to marijuana, alcohol, and/or cocaine.

Astley SJ, Clarren SK, Little RE, Sampson PD, Daling JR.

Pediatrics. 1992 Jan;89(1):67-77.

PMID:
1728025
46.

Holoprosencephaly in a fetal macaque (Macaca nemestrina) following weekly exposure to ethanol.

Siebert JR, Astley SJ, Clarren SK.

Teratology. 1991 Jul;44(1):29-36.

PMID:
1957260
47.

Neuroanatomic and neurochemical abnormalities in nonhuman primate infants exposed to weekly doses of ethanol during gestation.

Clarren SK, Astley SJ, Bowden DM, Lai H, Milam AH, Rudeen PK, Shoemaker WJ.

Alcohol Clin Exp Res. 1990 Oct;14(5):674-83.

PMID:
1979903
48.

Maternal marijuana use during lactation and infant development at one year.

Astley SJ, Little RE.

Neurotoxicol Teratol. 1990 Mar-Apr;12(2):161-8.

49.

Morphometric analysis of Macaca nemestrina exposed to ethanol during gestation.

Sheller B, Clarren SK, Astley SJ, Sampson PD.

Teratology. 1988 Nov;38(5):411-7.

PMID:
3238598
50.

Supplemental Content

Loading ...
Support Center